Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAD+ repletion with niacin counteracts cancer cachexia
Marc Beltrà, Noora Pöllänen, Claudia Fornelli, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

NAD metabolism: Role in senescence regulation and aging
Claudia C.S. Chini, Heidi Soares Cordeiro, Ngan Tran, et al.
Aging Cell (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 33
AMPK as a mediator of tissue preservation: time for a shift in dogma?
Henning T. Langer, Maria Rohm, Marcus D. Goncalves, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 9, pp. 526-540
Closed Access | Times Cited: 11
NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota
Julia Niño-Narvión, Marina Idalia Rojo-López, Patricia Martinez-Santos, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2992-2992
Open Access | Times Cited: 16
Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives
Moustafa Ghanem, Irene Caffa, Fiammetta Monacelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2092-2092
Open Access | Times Cited: 7
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Shalender Bhasin, Douglas R. Seals, Marie E. Migaud, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 6, pp. 1047-1073
Open Access | Times Cited: 14
Cancer cachexia: multilevel metabolic dysfunction
Mauricio Berriel Díaz, Maria Rohm, Stephan Herzig
Nature Metabolism (2024)
Closed Access | Times Cited: 5
Bifidobacterium adolescentis-derived nicotinic acid improves host skeletal muscle mitochondrial function to ameliorate sarcopenia
Zeng Zhang, Quan Guo, Zhihan Yang, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115265-115265
Open Access
GL261 glioblastoma induces delayed body weight gain and stunted skeletal muscle growth in young mice
Joshua R. Huot, Nicholas A. Jamnick, Fabrizio Pin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Human skeletal muscle possesses both reversible proteomic signatures and a retained proteomic memory after repeated resistance training
Juha J. Hulmi, Eeli J. Halonen, Adam P. Sharples, et al.
The Journal of Physiology (2025)
Closed Access
NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers
Xiaotong Zhu, Ye Li, Haixia Liu, et al.
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1203-1218.e17
Closed Access | Times Cited: 4
Systemic metabolic crosstalk as driver of cancer cachexia
Elisabeth Wyart, Giovanna Carrà, Elia Angelino, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
Progressive, multi‐organ, and multi‐layered nature of cancer cachexia
Yuki Nakamura, Don Pietro Saldajeno, Kosuke Kawaguchi, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 715-722
Open Access | Times Cited: 3
Tryptophan metabolism and kynurenine metabolites in cancer: systemic nutritional and metabolic implications
Alessio Molfino, Giovanni Imbimbo, Carmen Gallicchio, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2024) Vol. 27, Iss. 3, pp. 316-321
Closed Access | Times Cited: 3
Metabolomics‐driven discovery of therapeutic targets for cancer cachexia
Pengfei Cui, Xiaoyi Li, Caihua Huang, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 3, pp. 781-793
Open Access | Times Cited: 3
ALTERATIONS IN PEROXISOMAL-MITOCHONDRIAL INTERPLAY IN SKELETAL MUSCLE ACCELERATES MUSCLE DYSFUNCTION
Marco Scalabrin, E Turco, Leonardo Nogara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Preventing loss of sirt1 lowers mitochondrial oxidative stress and preserves C2C12 myotube diameter in an in vitro model of cancer cachexia
Brian A. Hain, Scot R. Kimball, David L. Waning
Physiological Reports (2024) Vol. 12, Iss. 13
Open Access | Times Cited: 3
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis, Nikolaοs Tentolouris, Natalia G. Vallianou, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 388-388
Open Access | Times Cited: 3
Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting
Joshua R. Huot, Dryden R. Baumfalk, Aridai Resendiz, et al.
Antioxidants and Redox Signaling (2022)
Open Access | Times Cited: 13
Increased Dietary Niacin Intake Improves Muscle Strength, Quality, and Glucose Homeostasis in Adults over 40 Years of Age
Shao Xiang, Yanping Li, Yanping Li, et al.
The journal of nutrition health & aging (2023) Vol. 27, Iss. 9, pp. 709-718
Open Access | Times Cited: 7
Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging
Fabio Penna, Giacomo Rubini, Paola Costelli
Molecular Aspects of Medicine (2024) Vol. 100, pp. 101318-101318
Open Access | Times Cited: 2
Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics
Na Sun, Tanja Krauss, Claudine Seeliger, et al.
Metabolism (2024), pp. 156034-156034
Open Access | Times Cited: 2
Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia
Yasushi Kojima, Emi Mishiro‐Sato, Teruaki Fujishita, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis
Ekaterina Podyacheva, Yana Toropova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7925-7925
Open Access | Times Cited: 5
NAD+: An old but promising therapeutic agent for skeletal muscle ageing
Yingying Xu, Weihua Xiao
Ageing Research Reviews (2023) Vol. 92, pp. 102106-102106
Open Access | Times Cited: 4
Pharmacotherapeutic options for cancer cachexia: emerging drugs and recent approvals
Lorena Garcia‐Castillo, Giacomo Rubini, Paola Costelli
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 9, pp. 1053-1065
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top